The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
The DOI matches its Crossref record; 791 of the 808 references it cites were found in a registry or an index.
Abstract
The inflammatory response is a highly regulated physiological process that is critically important for homeostasis. A precise physiological control of inflammation allows a timely reaction to invading pathogens or to other insults without causing overreaction liable to damage the host. The cellular signaling pathways identified as important regulators of inflammation are the signal transduction cascades mediated by the nuclear factor-kappaB and the activator protein-1, which can both be modulated by glucocorticoids. Their use in the clinic includes treatment of rheumatoid arthritis, asthma, allograft rejection, and allergic skin diseases. Although glucocorticoids have been widely used since the late 1940s, the molecular mechanisms responsible for their antiinflammatory activity are still under investigation. The various molecular pathways proposed so far are discussed in more detail.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It acts through the glucocorticoid receptor (GR), which modulates gene expression by suppressing pro-inflammatory signaling pathways involving transcription factors such as NF-κB and AP-1 [18].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [18]
In the citing paper
“GCs also decrease immune activation via protein-protein interactions between GR and NF-κB in the nucleus (Figure 1) (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“Moreover, chronic exposure to GCs (particularly synthetic GCs at supra-physiological levels) inhibits both innate and adaptive immunity.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“For example, chronic GC exposure reduces circulating leukocyte counts and decreases the production of a large variety of proinflammatory cytokines including IL-1β and TNF-α (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
Citations
Cites
2 retracted
Items 201–400 of 791
Thomson, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4779 · Cited by 450
D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L., Migliorati, G., & Riccardi, C. (1997) · Immunity · doi:10.1016/s1074-7613(00)80398-2 · Cited by 444
The p38 Mitogen-activated Protein Kinase Is Required for NF-κB-dependent Gene Expression
Carter, A. B., Knudtson, K. L., Monick, M. M., & Hunninghake, G. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30858 · Cited by 443
NF-κB Binds P-TEFb to Stimulate Transcriptional Elongation by RNA Polymerase II
Barboric, M., Nissen, R. M., Kanazawa, S., Jabrane-Ferrat, N., & Peterlin, B. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00314-8 · Cited by 435 · cited 2×
“Furthermore, NF-B was found to stimulate transcriptional elongation of RNA polymerase II by binding transcription elongation factor (P-TEFb), which phosphorylates RNA polymerase II CTD at Ser2 and Ser5 (606, 607).”
BackgroundTranscriptional Activation by NF-κB Requires Multiple Coactivators
Sheppard, K.-A., Rose, D. W., Haque, Z. K., Kurokawa, R., McInerney, E., Westin, S., Thanos, D., Rosenfeld, M. G., Glass, C. K., & Collins, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6367 · Cited by 434
Signal-induced ubiquitination of Ikappa Balpha by the F-box protein Slimb/beta -TrCP
Spencer, E., Jiang, J., & Chen, Z. J. (1999) · Genes & Development · doi:10.1101/gad.13.3.284 · Cited by 431
Yang, X., Phillips, D. L., Ferguson, A. T., Nelson, W. G., Herman, J. G., & Davidson, N. E. (2001) · PubMed · Cited by 430
Composite co-activator ARC mediates chromatin-directed transcriptional activation
Näär, A. M., Beaurang, P. A., Zhou, S., Abraham, S., Solomon, W., & Tjian, R. (1999) · Nature · doi:10.1038/19789 · Cited by 429
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
Reichardt, H. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7168 · Cited by 429
Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms
Li, N., & Karin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13012 · Cited by 427
A New First Step in Activation of Steroid Receptors
Davies, T. H., Ning, Y.-M., & Sánchez, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100531200 · Cited by 427
Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., & Matsushima, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36831-x · Cited by 424
Nitrosation and oxidation in the regulation of gene expression
Marshall, H. E., Merchant, K., & Stamler, J. S. (2000) · The FASEB Journal · doi:10.1096/fj.00.011rev · Cited by 424
Maniatis, T. (1999) · Genes & Development · doi:10.1101/gad.13.5.505 · Cited by 421
Ito, M., Yuan, C.-X., Malik, S., Gu, W., Fondell, J. D., Yamamura, S., Fu, Z.-Y., Zhang, X., Qin, J., & Roeder, R. G. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80463-3 · Cited by 419 · cited 2×
“Interestingly , PPAR-␣ ligand-dependent recruitment of vitamin D receptor-interacting protein (DRIP)/thyroid receptor-activated protein (TRAP) complex together with Sp1-flanking NF-B lies at the basis of the observed transcriptional synergy (265, 267).”
BackgroundMechanism of corepressor binding and release from nuclear hormone receptors
Nagy, L., Kao, H.-Y., Love, J. D., Li, C., Banayo, E., Gooch, J. T., Krishna, V., Chatterjee, K., Evans, R. M., & Schwabe, J. W. R. (1999) · Genes & Development · doi:10.1101/gad.13.24.3209 · Cited by 417
A Transcriptional Switch Mediated by Cofactor Methylation
Xu, W., Chen, H., Du, K., Asahara, H., Tini, M., Emerson, B. M., Montminy, M., & Evans, R. M. (2001) · Science · doi:10.1126/science.1065961 · Cited by 416
Molecular mechanisms of glucocorticoid action and resistance
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00263-7 · Cited by 416 · cited 2×
“GC-responsive tissues with an activated inflammatory response (mediated by activated NF- B) may become resistant to GC signaling because of a blocked GR function (180, 185, 698, 699).”
BackgroundIrusen, E., Matthews, J. G., Takahashi, A., Barnes, P. J., Chung, K. F., & Adcock, I. M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122465 · Cited by 416 · cited 3×
“Steroid-sensitive and steroid-resistant patients with Crohn’s disease reveal a remarkably different cellular activation pattern of proinflammatory mediators; steroid resistance was found to correlate with increased epithelial activation of stress-activated protein kinases (MAPK) and NF- B (161, 163, 710).”
BackgroundFu, M., Wang, C., Reutens, A. T., Wang, J., Angeletti, R. H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M.-L., & Pestell, R. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000660200 · Cited by 409 · cited 11×
“Fourth, mutants of AP-1 that lack the N-terminal transactivation domain still repress NRs, whereas the interaction with CBP is lost (95, 96).”
BackgroundInfluentialMechanisms of Glucocorticoid Action in Bone
CANALIS, E., & DELANY, A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04204.x · Cited by 406
Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity
Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., & Gallo, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.510 · Cited by 405
McKay, L. I., & Cidlowski, J. A. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.1.0044 · Cited by 405
Regulatory functions of ubiquitination in the immune system
Ben-Neriah, Y. (2002) · Nature Immunology · doi:10.1038/ni0102-20 · Cited by 402
Disassembly of Transcriptional Regulatory Complexes by Molecular Chaperones
Freeman, B. C., & Yamamoto, K. R. (2002) · Science · doi:10.1126/science.1073051 · Cited by 400 · cited 1×
“Other levels of regulation that determine GC sensitivity include variations in the receptor protein (mutations, polymorphisms, isoforms) (141– 147), alternative receptor dimerization (GR heterodimerization has been described with MR, PR, and AR) (144, 148–151), presence of GC modulatory element binding proteins (152–…”
BackgroundTNF-Induced Recruitment and Activation of the IKK Complex Require Cdc37 and Hsp90
Chen, G., Cao, P., & Goeddel, D. V. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00450-1 · Cited by 400
MAPK-regulated transcription: a continuously variable gene switch?
Hazzalin, C. A., & Mahadevan, L. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm715 · Cited by 400
The IKK complex: an integrator of all signals that activate NF-κB?
Israël, A. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01729-3 · Cited by 398
Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1
Bhattacharya, S., Michels, C. L., Leung, M.-K., Arany, Z. P., Kung, A. L., & Livingston, D. M. (1999) · Genes & Development · doi:10.1101/gad.13.1.64 · Cited by 395
Wallace, A. D., & Cidlowski, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106033200 · Cited by 394
FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent
Stenoien, D. L., Patel, K., Mancini, M. G., Dutertre, M., Smith, C. L., O'Malley, B. W., & Mancini, M. A. (2001) · Nature Cell Biology · doi:10.1038/35050515 · Cited by 393
Sizemore, N., Lerner, N., Dombrowski, N., Sakurai, H., & Stark, G. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110572200 · Cited by 390
Two Waves of Nuclear Factor κb Recruitment to Target Promoters
Saccani, S., Pantano, S., & Natoli, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1351 · Cited by 389
Transcriptional cross-talk, the second mode of steroid hormone receptor action
Göttlicher, M., Heck, S., & Herrlich, P. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050242 · Cited by 388 · cited 1×
“Jun/Fos heterodimer (456), unless one assumes that a GR-”
BackgroundChromodomains are protein–RNA interaction modules
Akhtar, A., Zink, D., & Becker, P. B. (2000) · Nature · doi:10.1038/35030169 · Cited by 385
AP-1: One Switch for Many Signals
Wisdom, R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4685 · Cited by 385
Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks
Robyr, D. (2000) · Molecular Endocrinology · doi:10.1210/me.14.3.329 · Cited by 381 · cited 2×
“specific subset of cofactors (261, 262) that may allow the GR to cooperate, perhaps even in a DNA-binding independent way, with other LPS- or TNF-activated transcription factors in the I B- -promoter.”
BackgroundInhibition of NF-κB by S-Nitrosylation
Marshall, H. E., & Stamler, J. S. (2001) · Biochemistry · doi:10.1021/bi002239y · Cited by 379
Wang, D., & Baldwin, A. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29411 · Cited by 375
The Rel/NF-κB family: friend and foe
Perkins, N. D. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01617-0 · Cited by 375
NAK is an IκB kinase-activating kinase
Tojima, Y., Fujimoto, A., Delhase, M., Chen, Y., Hatakeyama, S., Nakayama, K.-I., Kaneko, Y., Nimura, Y., Motoyama, N., Ikeda, K., et al. (2000) · Nature · doi:10.1038/35008109 · Cited by 375
Rapid Actions of Steroid Receptors in Cellular Signaling Pathways
Cato, A. C. B., Nestl, A., & Mink, S. (2002) · Science's STKE · doi:10.1126/stke.2002.138.re9 · Cited by 369
Wang, C., Fu, M., Angeletti, R. H., Siconolfi-Baez, L., Reutens, A. T., Albanese, C., Lisanti, M. P., Katzenellenbogen, B. S., Kato, S., Hopp, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100800200 · Cited by 366 · cited 11×
“Fourth, mutants of AP-1 that lack the N-terminal transactivation domain still repress NRs, whereas the interaction with CBP is lost (95, 96).”
BackgroundInfluentialDe Bosscher, K., Schmitz, M. L., Vanden Berghe, W., Plaisance, S., Fiers, W., & Haegeman, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13504 · Cited by 363
Self-citationDirect and Indirect Inhibition of Th1 Development by Progesterone and Glucocorticoids
Miyaura, H., & Iwata, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1087 · Cited by 361
Koh, S. S., Chen, D., Lee, Y.-H., & Stallcup, M. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004228200 · Cited by 358
Minireview: Nuclear Receptor Coactivators--An Update
McKenna, N. J., & O’Malley, B. W. (2002) · Endocrinology · doi:10.1210/en.143.7.2461 · Cited by 356
Steroid hormone receptors and their regulation by phosphorylation
WEIGEL, N. L. (1996) · Biochemical Journal · doi:10.1042/bj3190657 · Cited by 354
Berghe, W. V., De Bosscher, K., Boone, E., Plaisance, S., & Haegeman, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32091 · Cited by 354
Self-citationMerika, M., & Thanos, D. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00180-5 · Cited by 353
Negative Interaction between the RelA(p65) Subunit of NF-κB and the Progesterone Receptor
Kalkhoven, E., Wissink, S., van der Saag, P. T., & Burg, B. V. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6217 · Cited by 352
Ryu, S., Zhou, S., Ladurner, A. G., & Tjian, R. (1999) · Nature · doi:10.1038/17141 · Cited by 351 · cited 1×
“Several DRIP/ARC subunits are also components of other potentially related cofactor complexes, such as cofactor required for Sp1 (CRSP) (594), TRAP (595, 596), negative regulator of activated transcription (NAT) (597), and Srb/mediator coactivator complex (SMCC) (598), indicating that unique classes of activators may…”
BackgroundGlucocorticoids and immune function: unknown dimensions and new frontiers
Wilckens, T., & De Rijk, R. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01111-0 · Cited by 351
pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167
Joel, P. B., Smith, J., Sturgill, T. W., Fisher, T. L., Blenis, J., & Lannigan, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1978 · Cited by 345
De Bosscher, K., Vanden Berghe, W., Vermeulen, L., Plaisance, S., Boone, E., & Haegeman, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3919 · Cited by 335 · cited 3×
“Another way for GR-mediated repression might be the targeting of non-HAT-containing cofactors, bridging p65 or AP-1 activation domains to the RNA polymerase holoenzyme (240, 589) (Fig.”
BackgroundSelf-citationNuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
Caelles, C., González-Sancho, J. M., & Muñoz, A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3351 · Cited by 334 · cited 1×
“with activation of JNK and ERK1/2 (via increased MKP1 levels), which prevented AP-1 phosphorylation (283, 286, 552, 553) (Fig.”
BackgroundIKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex
Peters, R. T., Liao, S.-M., & Maniatis, T. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80445-1 · Cited by 333
Parry, G. C., & Mackman, N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5450 · Cited by 332
Cross‐talk between pro‐inflammatory transcription factors and glucocorticoids
Adcock, I. M., & Caramori, G. (2001) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2001.01025.x · Cited by 330
Sharp, an inducible cofactor that integrates nuclear receptor repression and activation
Shi, Y., Downes, M., Xie, W., Kao, H.-Y., Ordentlich, P., Tsai, C.-C., Hon, M., & Evans, R. M. (2001) · Genes & Development · doi:10.1101/gad.871201 · Cited by 329
Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts
Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T., & Grumont, R. (1999) · Oncogene · doi:10.1038/sj.onc.1203236 · Cited by 329
Regulation of cytokine and cytokine receptor expression by glucocorticoids
Almawi, W. Y., Beyhum, H. N., Rahme, A. A., & Rieder, M. J. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.5.563 · Cited by 328 · cited 1×
“pathways, effects on cytokine receptor expression (120, 121), regulation of thymocyte and lymphocyte survival, selection, and functions (122–126), as well as interference with eosinopoiesis (127) or erythropoiesis (128).”
BackgroundNew Twists in Gene Regulation by Glucocorticoid Receptor: Is DNA Binding Dispensable?
Karin, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81177-0 · Cited by 327
Multisite phosphorylation provides sophisticated regulation of transcription factors
Holmberg, C. I., Tran, S. E. F., Eriksson, J. E., & Sistonen, L. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02207-7 · Cited by 323
Nuclear receptor coregulators: multiple modes of modification
Hermanson, O., Glass, C. K., & Rosenfeld, M. G. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00527-6 · Cited by 322
Deciphering the Phosphorylation “Code” of the Glucocorticoid Receptor in Vivo
Wang, Z., Frederick, J., & Garabedian, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110530200 · Cited by 321 · cited 2×
“ulating distinct aspects of receptor function (168, 534, 547).”
BackgroundAyroldi, E., Migliorati, G., Bruscoli, S., Marchetti, C., Zollo, O., Cannarile, L., D'Adamio, F., & Riccardi, C. (2001) · Blood · doi:10.1182/blood.v98.3.743 · Cited by 320
GLUCOCORTICOID AND MINERALOCORTICOID RECEPTORS: Biology and Clinical Relevance
Funder, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.231 · Cited by 320
Biological roles and mechanistic actions of co-repressor complexes
Jepsen, K., & Rosenfeld, M. G. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.4.689 · Cited by 317
Transcription factors 3: nuclear receptors.
Gronemeyer, H., & Laudet, V. (1995) · PubMed · Cited by 315
(1995) · PubMed · Cited by 312
Vayssière, B. M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H., & Resche-Rigon, M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9979 · Cited by 311
Dong, Y., Poellinger, L., Gustafsson, J.-Å., & Okret, S. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1256 · Cited by 311 · cited 1×
“GR levels are themselves negatively regulated by GCs, contributing to the fact that long-term treatment with GCs results in a decrease of the physiological response (139, 140).”
BackgroundZacharchuk, C. M., Merćep, M., Chakraborti, P. K., Simons, S. S., & Ashwell, J. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4037 · Cited by 309
Molecular mechanisms of anti‐inflammatory action of glucocorticoids
Cato, A. C. B., & Wade, E. (1996) · BioEssays · doi:10.1002/bies.950180507 · Cited by 309 · cited 1×
“They suppress the production and effects of humoral factors involved in the inflammatory response (104, 196).”
BackgroundNeuroendocrine regulation of autoimmune/inflammatory disease
Sternberg, E. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690429 · Cited by 308 · cited 1×
“This includes signal transduction cascades elicited by different cell-cell contacts, systemic signals, GR metabolism, and neuroendocrine effects (178, 203, 316, 317).”
BackgroundSheppard, K.-A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G., Gerritsen, M. E., & Collins, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29291 · Cited by 305
Glucocorticoid-induced DNA demethylation and gene memory during development
Thomassin, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1974 · Cited by 305 · cited 1×
“Finally, a role for DNA methylation in both GR transrepression and transactivation has been described (497, 498).”
BackgroundRegulation of the transcriptional activity of the nuclear factor-κB p65 subunit
Vermeulen, L., De Wilde, G., Notebaert, S., Vanden Berghe, W., & Haegeman, G. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01161-9 · Cited by 304
Self-citationVanden Berghe, W., Vermeulen, L., De Wilde, G., De Bosscher, K., Boone, E., & Haegeman, G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00412-3 · Cited by 303
Self-citationRay, A., Prefontaine, K. E., & Ray, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99966-7 · Cited by 301
Inhibition of AP-1 by the Glucocorticoid-inducible Protein GILZ
Mittelstadt, P. R., & Ashwell, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101522200 · Cited by 301 · cited 1×
“Fas/Fas-L during TCR responses (642, 645, 647) (Fig.”
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
Nuclear compartmentalization and gene activity
Francastel, C., Schübeler, D., Martin, D. I. K., & Groudine, M. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040083 · Cited by 297
Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase
Rogatsky, I., Logan, S. K., & Garabedian, M. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2050 · Cited by 297
The glucocorticoid receptor is required for stress erythropoiesis
Bauer, A., Tronche, F., Wessely, O., Kellendonk, C., Reichardt, H. M., Steinlein, P., Schutz, G., & Beug, H. (1999) · Genes & Development · doi:10.1101/gad.13.22.2996 · Cited by 296 · cited 1×
“pathways, effects on cytokine receptor expression (120, 121), regulation of thymocyte and lymphocyte survival, selection, and functions (122–126), as well as interference with eosinopoiesis (127) or erythropoiesis (128).”
BackgroundIkappa Balpha -independent downregulation of NF-kappa B activity by glucocorticoid receptor
Heck, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.15.4698 · Cited by 295 · cited 4×
“Reciprocally, the GC analogs ZK57740 and ZK077945, selected for their lack of antiinflammatory activities in vivo, do not repress NF- B-regulated genes but can still enhance I B- synthesis (256).”
BackgroundResultInfluentialFarrell, R. J., Murphy, A., Long, A., Donnelly, S., Cherikuri, A., O'Toole, D., Mahmud, N., Keeling, P. W. N., Weir, D. G., & Kelleher, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70210-1 · Cited by 291 · cited 1×
“NR mutations affecting ligand binding or cofactor affinities, changed cofactor expression levels, NF- B-dependent expression of the multidrug resistance protein MDR1, oncogenic activation of growth factorsignaling pathways, and altered circuitry in nongenomic NR pathways (549, 720, 721).”
BackgroundNuclear receptors: integration of multiple signalling pathways through phosphorylation
Rochette-Egly, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00115-8 · Cited by 291
Berrebi, D., Bruscoli, S., Cohen, N., Foussat, A., Migliorati, G., Bouchet-Delbos, L., Maillot, M.-C., Portier, A., Couderc, J., Galanaud, P., et al. (2003) · Blood · doi:10.1182/blood-2002-02-0538 · Cited by 290
IKAP is a scaffold protein of the IκB kinase complex
Cohen, L., Henzel, W. J., & Baeuerle, P. A. (1998) · Nature · doi:10.1038/26254 · Cited by 288
Recent insights into the mechanism of glucocorticosteroid-induced apoptosis
Distelhorst, C. W. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400969 · Cited by 287 · cited 3×
“or apoptotic properties is not clear yet (124, 126, 630).”
BackgroundThe orphan nuclear receptor RORα is a negative regulator of the inflammatory response
Delerive, P., Monté, D., Dubois, G., Trottein, F., Fruchart‐Najib, J., Mariani, J., Fruchart, J., & Staels, B. (2001) · EMBO reports · doi:10.1093/embo-reports/kve007 · Cited by 286 · cited 1×
“In addition, synergistic stimulation of the I B- promoter can also be observed under conditions of activated NF- B and peroxisome proliferator-activated receptor PPAR- or the retinoid-related orphan receptor (ROR)- (265, 266).”
BackgroundInvolvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation
Béraud, C., Henzel, W. J., & Baeuerle, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.429 · Cited by 281
Mediator complexes and transcription
Rachez, C., & Freedman, L. P. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00209-x · Cited by 281
Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.
Greenstein, S., Ghias, K. K., Krett, N. L., & Rosen, S. T. (2002) · PubMed · Cited by 279
Hittelman, A. B. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5380 · Cited by 276
A Novel Human SRB/MED-Containing Cofactor Complex, SMCC, Involved in Transcription Regulation
Gu, W., Malik, S., Ito, M., Yuan, C.-X., Fondell, J. D., Zhang, X., Martinez, E., Qin, J., & Roeder, R. G. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80178-1 · Cited by 276 · cited 1×
“Several DRIP/ARC subunits are also components of other potentially related cofactor complexes, such as cofactor required for Sp1 (CRSP) (594), TRAP (595, 596), negative regulator of activated transcription (NAT) (597), and Srb/mediator coactivator complex (SMCC) (598), indicating that unique classes of activators may…”
BackgroundThe Glucocorticoid Receptor: Coding a Diversity of Proteins and Responses through a Single Gene
Yudt, M. R., & Cidlowski, J. A. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0106 · Cited by 275
Regulation and Physiological Roles of Serum- and Glucocorticoid-Induced Protein Kinase Isoforms
Lang, F., & Cohen, P. (2001) · Science's STKE · doi:10.1126/stke.2001.108.re17 · Cited by 274
General Presence of Glucocorticoid Receptors in Mammalian Tissues1
BALLARD, P. L., BAXTER, J. D., HIGGINS, S. J., ROUSSEAU, G. G., & TOMKINS, G. M. (1974) · Endocrinology · doi:10.1210/endo-94-4-998 · Cited by 272 · cited 1×
“Because GR is expressed in the vast majority of tissues, it is reasonable to assume that GCs affect nearly all cells in the body (130).”
BackgroundMaeda, H., & Shiraishi, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.73 · Cited by 272
Mikosz, C. A., Brickley, D. R., Sharkey, M. S., Moran, T. W., & Conzen, S. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010842200 · Cited by 271
Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor
Knutti, D., Kressler, D., & Kralli, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171184698 · Cited by 271 · cited 1×
“Interestingly, p38 MAPK has been shown to induce GR phosphorylation and to regulate ligand-binding and coregulator affinity (163, 544).”
BackgroundTobler, A., Meier, R., Seitz, M., Dewald, B., Baggiolini, M., & Fey, M. (1992) · Blood · doi:10.1182/blood.v79.1.45.45 · Cited by 270
Folding of the Glucocorticoid Receptor by the Heat Shock Protein (hsp) 90-based Chaperone Machinery
Dittmar, K. D., Demady, D. R., Stancato, L. F., Krishna, P., & Pratt, W. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21213 · Cited by 268
Krstic, M. D., Rogatsky, I., Yamamoto, K. R., & Garabedian, M. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3947 · Cited by 268
McCormick, J. A. (2000) · Molecular Endocrinology · doi:10.1210/me.14.4.506 · Cited by 265
De Bosscher, K. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00297-6 · Cited by 264
Self-citationHelmberg, A., Auphan, N., Caelles, C., & Karin, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07021.x · Cited by 262 · cited 1×
“On the contrary, other experimental set-ups with GR mutants that lack transactivation but retain NF- B and AP-1 transrepression capacity, point to an intact GC-induced apoptosis (637).”
ResultCosma, M. P. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00604-4 · Cited by 262
Webster, J. C., Jewell, C. M., Bodwell, J. E., Munck, A., Sar, M., & Cidlowski, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9287 · Cited by 261
Nuclear Hormone Receptors in T Lymphocytes
Winoto, A., & Littman, D. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00710-9 · Cited by 260
Dexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38
Lasa, M., Brook, M., Saklatvala, J., & Clark, A. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.771-780.2001 · Cited by 259
Silverstein, A. M., Galigniana, M. D., Chen, M.-S., Owens-Grillo, J. K., Chinkers, M., & Pratt, W. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16224 · Cited by 257
Okret, S., Poellinger, L., Dong, Y., & Gustafsson, J. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5899 · Cited by 256 · cited 1×
“GR levels are themselves negatively regulated by GCs, contributing to the fact that long-term treatment with GCs results in a decrease of the physiological response (139, 140).”
BackgroundRay, P., Ghosh, S. K., Zhang, D.-H., & Ray, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00487-0 · Cited by 256 · cited 1×
“GR, ER, and TR ) has proven the importance of the GR DBD both in transactivation and transrepression (102, 211, 230).”
BackgroundChen, J. Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., & Gronemeyer, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07102.x · Cited by 255
Fernandes, I., Bastien, Y., Wai, T., Nygard, K., Lin, R., Cormier, O., Lee, H. S., Eng, F., Bertos, N. R., Pelletier, N., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00014-5 · Cited by 255 · cited 1×
“The key question to be addressed is whether a distinct GR cofactor configuration is involved in repression of NF- B-mediated gene expression (361, 362, 443, 461).”
BackgroundCREB-binding protein in androgen receptor-mediated signaling
Aarnisalo, P., Palvimo, J. J., & Jänne, O. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2122 · Cited by 255
Virus Infection Leads to Localized Hyperacetylation of Histones H3 and H4 at the IFN-β Promoter
Parekh, B. S., & Maniatis, T. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80181-1 · Cited by 255
Wagner, B. L., Norris, J. D., Knotts, T. A., Weigel, N. L., & McDonnell, D. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1369 · Cited by 255
Caldenhoven, E. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.401 · Cited by 253
Honda, M., Orii, F., Ayabe, T., Imai, S., Ashida, T., Obara, T., & Kohgo, Y. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70172-7 · Cited by 252 · cited 1×
“However, the biological significance of this dominantnegative effect by GR- has been questioned, because it is expressed at rather low levels (706, 707).”
BackgroundInduction of cytokine receptors by glucocorticoids: functional and pathological significance
Wiegers, G. J., & Reul, J. M. H. M. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01229-2 · Cited by 251
TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα
Arsura, M., Wu, M., & Sonenshein, G. E. (1996) · Immunity · doi:10.1016/s1074-7613(00)80307-6 · Cited by 250
Kasibhatla, S., Genestier, L., & Green, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.987 · Cited by 250
Grumont, R. J., Rourke, I. J., O'Reilly, L. A., Strasser, A., Miyake, K., Sha, W., & Gerondakis, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.663 · Cited by 249
RNA polymerase II elongation through chromatin
Orphanides, G., & Reinberg, D. (2000) · Nature · doi:10.1038/35035000 · Cited by 243
How many nuclear hormone receptors are there in the human genome?
Robinson-Rechavi, M., Carpentier, A.-S., Duffraisse, M., & Laudet, V. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02417-9 · Cited by 242
Phosphorylation of Steroid Hormone Receptors*
ORTÍ, E., BODWELL, J. E., & MUNCK, A. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-105 · Cited by 241
Vacca, A., Felli, M. P., Farina, A. R., Martinotti, S., Maroder, M., Screpanti, I., Meco, D., Petrangeli, E., Frati, L., & Gulino, A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.3.637 · Cited by 241
Oxidative stress interference with the nuclear factor- κB activation pathways
Schoonbroodt, S., & Piette, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00371-3 · Cited by 240
STAT3 Acts as a Co-activator of Glucocorticoid Receptor Signaling
Zhang, Z., Jones, S., Hagood, J. S., Fuentes, N. L., & Fuller, G. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30607 · Cited by 240
Synergistic, p160 Coactivator-dependent Enhancement of Estrogen Receptor Function by CARM1 and p300
Chen, D., Huang, S.-M., & Stallcup, M. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005459200 · Cited by 238
Itoh, M., Adachi, M., Yasui, H., Takekawa, M., Tanaka, H., & Imai, K. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0144 · Cited by 238 · cited 1×
“ulating distinct aspects of receptor function (168, 534, 547).”
BackgroundSubnuclear Trafficking of Estrogen Receptor-α and Steroid Receptor Coactivator-1
Stenoien, D. L., Mancini, M. G., Patel, K., Allegretto*, E. A., Smith, C. L., & Mancini, M. A. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.4.0436 · Cited by 237
Chen, D., Washbrook, E., Sarwar, N., Bates, G. J., Pace, P. E., Thirunuvakkarasu, V., Taylor, J., Epstein, R. J., Fuller-Pace, F. V., Egly, J.-M., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205420 · Cited by 236
Collart, M. A., Baeuerle, P., & Vassalli, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1498-1506.1990 · Cited by 235
IκB-independent control of NF-κB activity by modulatory phosphorylations
Schmitz, M. L., Bacher, S., & Kracht, M. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01753-9 · Cited by 234
Core promoters: active contributors to combinatorial gene regulation: Figure 1.
Smale, S. T. (2001) · Genes & Development · doi:10.1101/gad.937701 · Cited by 233
Na, S.-Y., Kang, B. Y., Chung, S. W., Han, S.-J., Ma, X., Trinchieri, G., Im, S.-Y., Lee, J. W., & Kim, T. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7674 · Cited by 233
Kleinert, H., Euchenhofer, C., Ihrig-Biedert, I., & Förstermann, U. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08682-1 · Cited by 233
RISTIMÄKI, A., NARKO, K., & HLA, T. (1996) · Biochemical Journal · doi:10.1042/bj3180325 · Cited by 232
Sun, X., Zhang, Y., Cho, H., Rickert, P., Lees, E., Lane, W., & Reinberg, D. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80131-8 · Cited by 232 · cited 1×
“Several DRIP/ARC subunits are also components of other potentially related cofactor complexes, such as cofactor required for Sp1 (CRSP) (594), TRAP (595, 596), negative regulator of activated transcription (NAT) (597), and Srb/mediator coactivator complex (SMCC) (598), indicating that unique classes of activators may…”
BackgroundCross-talk between glucocorticoid receptor and AP-1
Herrlich, P. (2001) · Oncogene · doi:10.1038/sj.onc.1204388 · Cited by 230 · cited 1×
“In vivo footprinting experiments of the NF- B site in the ICAM promoter further proved that GC repression occurs by changing the conformation of the protein complex binding to the NF- B-binding site, without apparent perturbation of NF- B binding (87, 271).”
BackgroundSaccani, S., & Natoli, G. (2002) · Genes & Development · doi:10.1101/gad.232502 · Cited by 226
Rogatsky, I., Luecke, H. F., Leitman, D. C., & Yamamoto, K. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262671599 · Cited by 226
A Dual Mechanism Mediates Repression of NF-κB Activity by Glucocorticoids
Wissink, S., van Heerde, E. C., van der Burg, B., & van der Saag, P. T. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.3.0081 · Cited by 225
Ma, H., Baumann, C. T., Li, H., Strahl, B. D., Rice, R., Jelinek, M. A., Aswad, D. W., Allis, C. D., Hager, G. L., & Stallcup, M. R. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00600-5 · Cited by 224
A Novel Antiinflammatory Maintains Glucocorticoid Efficacy with Reduced Side Effects
Coghlan, M. J., Jacobson, P. B., Lane, B., Nakane, M., Lin, C. W., Elmore, S. W., Kym, P. R., Luly, J. R., Carter, G. W., Turner, R., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0355 · Cited by 224
Proteasomal regulation of nuclear receptor corepressor-mediated repression
Zhang, J., Guenther, M. G., Carthew, R. W., & Lazar, M. A. (1998) · Genes & Development · doi:10.1101/gad.12.12.1775 · Cited by 223
Mechanism for Nucleocytoplasmic Shuttling of Histone Deacetylase 7
Kao, H.-Y., Verdel, A., Tsai, C.-C., Simon, C., Juguilon, H., & Khochbin, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107631200 · Cited by 223 · cited 1×
“Nucleocytoplasmic shuttling is finally also affected by cofactor phosphorylation (407, 408).”
BackgroundSequential DNA damage-independent and -dependent activation of NF-kappa B by UV
Bender, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5170 · Cited by 223
Yang, Y., Merćep, M., Ware, C. F., & Ashwell, J. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1673 · Cited by 223
CREB Binding Protein Is a Coactivator for the Androgen Receptor and Mediates Cross-talk with AP-1
Frønsdal, K., Engedal, N., Slagsvold, T., & Saatcioglu, F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31853 · Cited by 222
Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor
Savory, J. G. A., Hsu, B., Laquian, I. R., Giffin, W., Reich, T., Haché, R. J. G., & Lefebvre, Y. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1025 · Cited by 222
Dixit, V., & Mak, T. W. (2002) · Cell · doi:10.1016/s0092-8674(02)01166-2 · Cited by 221
Glucocorticoids Enhance Oxidative Stress-Induced Cell Death in Hippocampal Neurons in Vitro
Behl, C. (1997) · Endocrinology · doi:10.1210/en.138.1.101 · Cited by 220
Human IAP-Like Protein Regulates Programmed Cell Death Downstream of Bcl-x L and Cytochrome c
Duckett, C. S., Li, F., Wang, Y., Tomaselli, K. J., Thompson, C. B., & Armstrong, R. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.608 · Cited by 217
Strickland, I., Kisich, K., Hauk, P. J., Vottero, A., Chrousos, G. P., Klemm, D. J., & Leung, D. Y. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.585 · Cited by 215
Mutual Transcriptional Interference between RelA and Androgen Receptor
Palvimo, J. J., Reinikainen, P., Ikonen, T., Kallio, P. J., Moilanen, A., & Jänne, O. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24151 · Cited by 214
Membrane‐Initiated Steroid Actions and theProteins that Mediate Them
Watson, C. S., & Gametchu, B. (1999) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-2.x · Cited by 212
Nishio, Y., Isshiki, H., Kishimoto, T., & Akira, S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1854-1862.1993 · Cited by 211
Falkenstein, E., Meyer, C., Eisen, C., Scriba, P. C., & Wehling, M. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1761 · Cited by 211 · cited 1×
“(663), a specific isoform (664, 665), or a modified version of”
BackgroundKumar, R., & Thompson, E. B. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0258 · Cited by 210 · cited 1×
“share a variable amino-terminal transactivation domain (98),”
Lee, S.-K., Kim, H.-J., Na, S.-Y., Kim, T. S., Choi, H.-S., Im, S.-Y., & Lee, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16651 · Cited by 207
Burke, L. J., & Baniahmad, A. (2000) · The FASEB Journal · doi:10.1096/fj.99-0943rev · Cited by 207
Molecular Chaperone Interactions with Steroid Receptors: an Update
Cheung, J. C. Y., & Smith, D. F. (2000) · Molecular Endocrinology · doi:10.1210/me.14.7.939 · Cited by 207
Coordination of a Transcriptional Switch by HMGI(Y) Acetylation
Munshi, N., Agalioti, T., Lomvardas, S., Merika, M., Chen, G., & Thanos, D. (2001) · Science · doi:10.1126/science.293.5532.1133 · Cited by 206
Non-genomic effects of glucocorticoids in the neural system
Makara, G. B., & Haller, J. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00012-0 · Cited by 205
Shen, T., Horwitz, K. B., & Lange, C. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6122-6131.2001 · Cited by 204
Protein modules that manipulate histone tails for chromatin regulation
Marmorstein, R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073047 · Cited by 203 · cited 3×
“By analogy with histone code (465, 469, 470, 517), the interplay of modifications at the cofactor (370, 371) and transcription factor levels (418, 518–521) may similarly have important functional implications (such as, e.”
BackgroundRachez, C., Gamble, M., Chang, C.-P. B., Atkins, G. B., Lazar, M. A., & Freedman, L. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2718-2726.2000 · Cited by 203 · cited 1×
“Whether this mechanism can be generalized for the GR and/or other cell types needs to be investigated further (268).”
BackgroundLi, Q., Estepa, G., Memet, S., Israel, A., & Verma, I. M. (2000) · Genes & Development · doi:10.1101/gad.14.14.1729 · Cited by 203
Mayr, B. M., Canettieri, G., & Montminy, M. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191152098 · Cited by 202
Antagonism between Nur77 and Glucocorticoid Receptor for Control of Transcription
Philips, A., Maira, M., Mullick, A., Chamberland, M., Lesage, S., Hugo, P., & Drouin, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5952 · Cited by 201 · cited 1×
“GR tethering of the transcription factors CREB, AP-1, or the orphan NR Nurr-77 has been studied in detail in the human glycoprotein hormone -subunit (216, 217), the collagenase gene (96, 218), and the POMC gene (212, 219), respectively.”
BackgroundControl of CBP co-activating activity by arginine methylation
Chevillard-Briet, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf548 · Cited by 200
Androgen and Glucocorticoid Receptor Heterodimer Formation
Chen, S.-Y., Wang, J., Yu, G.-Q., Liu, W., & Pearce, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14087 · Cited by 200
Dressel, U., Thormeyer, D., Altincicek, B., Paululat, A., Eggert, M., Schneider, S., Tenbaum, S. P., Renkawitz, R., & Baniahmad, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3383 · Cited by 199
Molecular Chaperones: Biology and Prospects for Pharmacological Intervention
Smith, D. F., Whitesell, L., & Katsanis, E. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01380-2 · Cited by 198
Brostjan, C., Anrather, J., Csizmadia, V., Stroka, D., Soares, M., Bach, F. H., & Winkler, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19612 · Cited by 198 · cited 23×
“Only recently, Adcock et al. (229) succeeded in showing an interaction between endogenous p65 and GR, using IL-1- and dexamethasone (DEX)-costimulated A549 cells, which contain a considerable amount of immunoreactive GR.”
BackgroundInfluentialPaliogianni, F., Raptis, A., Ahuja, S. S., Najjar, S. M., & Boumpas, D. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116353 · Cited by 198
Tuckermann, J. P., Reichardt, H. M., Arribas, R., Richter, K. H., Schütz, G., & Angel, P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.7.1365 · Cited by 196
Regulation of Immune Responses by NF-κB/Rel Transcription Factors
Sha, W. C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.143 · Cited by 195
Almawi, W. Y., & Melemedjian, O. K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.9 · Cited by 195 · cited 1×
“or apoptotic properties is not clear yet (124, 126, 630).”
BackgroundHSP70 Protects against TNF-Induced Lethal Inflammatory Shock
Van Molle, W., Wielockx, B., Mahieu, T., Takada, M., Taniguchi, T., Sekikawa, K., & Libert, C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00310-2 · Cited by 191
Shemshedini, L., Knauthe, R., Sassone-Corsi, P., Pornon, A., & Gronemeyer, H. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04953.x · Cited by 189 · cited 1×
“on promoter, receptor, and cell type (248, 249).”
BackgroundHigh Constitutive NF-κB Activity Mediates Resistance to Oxidative Stress in Neuronal Cells
Lezoualc’h, F., Sagara, Y., Holsboer, F., & Behl, C. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03224.1998 · Cited by 187
Belvisi, M. G., Wicks, S. L., Battram, C. H., Bottoms, S. E. W., Redford, J. E., Woodman, P., Brown, T. J., Webber, S. E., & Foster, M. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1975 · Cited by 186 · cited 1×
“This includes signal transduction cascades elicited by different cell-cell contacts, systemic signals, GR metabolism, and neuroendocrine effects (178, 203, 316, 317).”
BackgroundPérarnau, B., Saron, M.-F., San Martin, B. R., Bervas, N., Ong, H., Soloski, M. J., Smith, A. G., Ure, J. M., Gairin, J. E., & Lemonnier, F. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04<1243::aid-immu1243>3.0.co;2-a · Cited by 186
Nongenomic membrane actions of glucocorticoids in vertebrates
Borski, R. J. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00325-8 · Cited by 184
Weinmann, A. S., Plevy, S. E., & Smale, S. T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80141-7 · Cited by 183
Achieving transcriptional specificity with nf-κb
Perkins, N. D. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00088-5 · Cited by 183
Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor
TIAN, S., POUKKA, H., PALVIMO, J. J., & JÄNNE, O. A. (2002) · Biochemical Journal · doi:10.1042/bj20021085 · Cited by 182
Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2002) · Science · doi:10.1126/science.1070442 · Cited by 179
Deciphering gene expression regulatory networks
Wyrick, J. J., & Young, R. A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00277-0 · Cited by 179
Li, Y., Kang, J., Friedman, J., Tarassishin, L., Ye, J., Kovalenko, A., Wallach, D., & Horwitz, M. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1042 · Cited by 179
Regulation of nuclear factor κB activation by G-protein-coupled receptors
Ye, R. D. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.839 · Cited by 178
Modifying Gene Expression Programs by Altering Core Promoter Chromatin Architecture
Lomvardas, S., & Thanos, D. (2002) · Cell · doi:10.1016/s0092-8674(02)00822-x · Cited by 178
Research works printed but not linked: 10
- Delerive, 2002, DNA-binding independent regulation of IκB-α gene transcription by PPARα., Mol Endocrinol, 16, 1029
- Benecke, 1998, Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap., Gene Ther Mol Biol, 3, 1
- Herrlich, 2001, Cross-talk between glucocorticoid receptor and AP-1., Oncogene, 20, 2465, 10.1038/sj.onc.1204388 · DOI · Paper page
- Lidén, 2000, Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene., Biochem Biophys Res Commun, 273, 1008, 10.1006/bbrc.2000.3079 · DOI
- Chen, 1999, Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells., J Cell Biochem, 74, 418, 10.1002/(sici)1097-4644(19990901)74:3<418::aid-jcb10>3.0.co;2-6 · DOI
- Webster, 2001, Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance., Proc Natl Acad Sci USA, 98, 6865, 10.1073/pnas.121455098 · DOI · Paper page
- De Vera, 1997, Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB, Am J Physiol, 273, G1290
- Han, 1999, Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide., Eur J Immunol, 29, 1334, 10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0 · doi:10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0
- Sengupta, 2000, Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells., EMBO J, 19, 6051, 10.1093/emboj/19.22.6051 · DOI
- Lee, 1998, Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter., EMBO J, 17, 1454, 10.1093/emboj/17.5.1454 · DOI
Cited by
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
“Nuclear receptors (NRs) are transcription factors that are typically regulated by the binding of specific ligands, such as glucocorticoids, oestrogen, thyroid hormone and retinoic aci”
BackgroundGene-specific control of inflammation by TLR-induced chromatin modifications
Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344
Metadata
- Authors
- De Bosscher, K., Vanden Berghe, W., & Haegeman, G.
- Affiliations
- Department of Molecular Biology, Ghent University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium
- Ghent University (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 488-522
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2053125671
- Cited by
- 898
- References
- 808
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 13 · 2023: 24 · 2022: 22 · 2021: 41 · 2020: 30 · 2019: 20 · 2018: 26 · 2017: 46 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 41 · 2012: 48
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glucocorticoid receptor, NF-κB, activator protein-1, gene repression, anti-inflammatory mechanism, inflammation, signal transduction, glucocorticoids, transcriptional regulation, rheumatoid arthritis, asthma, allograft rejection, allergic skin diseases
- MeSH terms
- Gene Expression Regulation, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid, Signal Transduction, NF-kappa B, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.